Related Experiment Video

Updated: Dec 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.0K

DNA vaccination against oncoantigens: A promise

Manuela Iezzi1, Elena Quaglino, Augusto Amici

  • 1Aging Research Centre; G. d'Annunzio University; Chieti, Italy.

Oncoimmunology
|June 28, 2012
PubMed

Insights

DNA vaccines show promise for treating cancer by eliciting protective immune responses. Recent advances are bridging the gap between experimental success and clinical application for these oncoantigen-targeted therapies.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • DNA vaccines demonstrate efficacy in preclinical models and canine cancer patients.
  • The US Food and Drug Administration (FDA) has approved a DNA vaccine for canine tumors.
  • A gap exists between experimental DNA vaccine data and clinical utility.

Purpose of the Study:

  • To review conceptual and biotechnological advances in DNA vaccine development.
  • To highlight the potential of DNA vaccines targeting oncoantigens for cancer treatment.

Main Methods:

  • Review of existing literature on DNA vaccine technology.
  • Analysis of conceptual and biotechnological progress in the field.

Main Results:

  • Emerging evidence supports protective immune responses from DNA vaccines.
  • Advances are facilitating the clinical application of DNA vaccines.
  • Oncoantigen-targeted DNA vaccines show promise for near-term clinical impact.

Conclusions:

  • Conceptual and biotechnological progress is enhancing DNA vaccine efficacy.
  • DNA vaccines targeting oncoantigens represent a promising therapeutic strategy.
  • Near-term clinical impact of DNA vaccines in oncology is anticipated.

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.2K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
878
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Vaccinations01:51

Vaccinations

Overview
50.9K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K